Combined use of erythrocyte zinc protoporphyrin and mean corpuscular volume in differentiation of thalassemia from iron deficiency anemia

European Journal of Haematology

Volumn 60, Issue 4, 1998, Pages 245-251

  Harthoorn Lasthuizen, Else J ^a   Lindemans, Jan ^b   Langenhuijsen, Mart M A C ^c  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Iron deficiency; Mean corpuscular volume; Thalassemia; Zinc protoporphyrin

Indexed keywords

ERYTHROCYTE PROTOPORPHYRIN; HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ERYTHROCYTE COUNT; FEMALE; HUMAN; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MICROCYTOSIS; PRIORITY JOURNAL; THALASSEMIA;

EID: 0031981756     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01031.x     Document Type: Article

References (27)

1. MENTZER WC. Differentiation of iron deficiency from thalassaemia trait. Lancet 1973: i: 882.
2. ENGLAND JM, FRASER PM. Differentiation of iron deficiency from thalassaemia trait by routine blood-count. Lancet 1973: i: 449-452.
3. SHINE I, LAL S. A strategy to detect beta thalassaemia minor. Lancet 1977: ii: 692-694.
4. STOCKMAN JA, WEINER LS, SIMON GE, STUART MJ, OSKI FA. The measurement of free erythrocytc porphyrin (FEP) as a simple means of distinguishing iron deficiency from betathalassemia trait in subjects with microcytosis. J Lab Clin Med 1975: 85: 113-119.
5. KOENIG HM, LIGHTSEY AL, SCHANBERGER JE. The micromeasurement of free erythrocyte protoporphyrin as a means of differentiating alpha thalassemia trait from iron deficiency anemia. J Pediatr 1975: 86: 539-541.
6. MELONI T, GALLISAI D, DEMONTIS M, ERRK S. Free erythrocyle porphyrin in the diagnosis of b-thalassaemia trait and iron deficiency anaemia. Haematologica 1982: 67: 341-348.
7. MARSH WL, NELSON DP, KOENIG HM. Free Erythrocyte Protoporphyrin FEP II. The FEP test is clinically useful in classifying microcytic RBC disorders in adults. Am J Clin Pathol 1983: 79: 661-666.
8. BELLOTH V, BERGAMASCHI G, CALDKRA D, et al. Clinical evaluation of erythrocyte zinc protoporphyrin as a parameter of iron status in man. Haematologica 1984: 69: 272-284.
9. HERSHKO C, KONIJN AM, LINK G, MOREB J, GRAUER F, WEISSENBERG E. Combined use of zinc protoporphyrin (ZPP), mean corpuscular volume and haemoglobin measurements for classifying microcytic RBC disorders in children and young adults. Clin Lab Haematol 1985: 7: 259-269.
10. TILLYER ML, TILLYER CR. Use of red cell distribution width and erythrocyte zinc protoporphyrin in differential diagnosis of alpha and beta thalassaemia and iron deficiency. J Clin Pathol 1994: 47: 205-208.
11. SCHIFMAN RB, FINLEY PR. Measurement of near-normal concentrations of erythrocyte protoporphyrin with the hematofluorimeter: influence of plasma on front surface illumination assay. Clin Chem 1981: 27: 153-156.
12. GALAN P, MEKKI N, HEREBERG S. Effect of sample storage on the assay of erythrocyte protoporphyrin by the hematofluoromcter method. Acta Haematol 1987: 78: 57-58.
13. BOWDEN DK, VICKERS MA, HIGGS DR. A PCR-based strategy to detect the common severe determinants of α-thalassemia. Br J Haematol 1992: 81: 104-108.
14. DODÉ C, KRISHNAMOORTHY R, LAMB J, ROCHETTE J. Rapid analysis of -α(3.7) thalassemia and ααα(anti 3.7) triplication by enzymatic amplification analysis. Br J Haematol 1992: 82: 105-111.
15. ENGLAND JM, FRASER PM. Differentiation of iron deficiency from beta-thalassaemia trait. Lancet 1973: i: 1514.
16. ENGLAND JM, FRASER PM. Discrimination between iron-deficiency and heterozygous thalassemia syndromes in differential diagnosis of microcytosis. Lancet 1979: i: 145-147.
17. POOTRAKUL P, WATTANASAREE J, ANUWATANAKULCHAI M, WASI P. Increased red blood cell protoporphyrin in thalassemia: a result of relative iron deficiency. Am J Clin Pathol 1984: 82: 289-293.
18. HAN P, FUNG KP, TEO CP, TAM LP. A-thalassaemia and b-thalassaemia traits: biological difference based on red cell indices and zinc protoporphyrin. Clin Lab Haematol 1990: 12: 169-176.
19. HINCHLIFFE RF, LILLEYMAN JS, STEEL GJ, BELLAMY GJ. Usefulness of red cell zinc protoporphyrin concentration in the investigation of microcytosis in children. Pediatr Hematol Oncol 1995: 12: 455-462.
20. GRAHAM EA, FELGENHAUER J, DETTER JC, LABBE RF. Elevated zinc protoporphyrin associated with thalassemia trait and hemoglobin E. J Pediatr 1996: 129: 105-110.
21. LABBE RF, RETTMER RL. Zinc protoporphyrin: a product of iron deficient erythropoiesis. Semin Haematol 1989: 1: 40-46.
22. CASH JM, SEARS DA. The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients. Am J Med 1989: 87: 638-644.
23. LABBE RF. Clinical utility of zinc protoporphyrin. Clin Chem 1992: 38: 2167-2168.
24. HASTKA J, LASSERRE JJ, SCHWARZBECK A, STRAUCH M, HEHLMANN R. Zinc protoporphyrin in anemia of chronic disorders. Blood 1993: 81: 1200-1204.
25. HINCHLIFFE RF, LILLEYMAN JS. Frequency of coincident iron deficiency and β-thalassaemia trait in British Asian children. J Clin Pathol 1995: 48: 594-595.
26. ALPERIN JB, Dow PA, PETTEWAY MB. Hemoglobin A2 levels in health and various hematologic disorders. Am J Clin Pathol 1977: 67: 219-226.
27. BLUMBRRG WE, EISINGER J, LAMOLA AA. Zinc protoporphyrin level in blood determined by a portable hematofluorometer: a screening device for lead poisoning. J Lab Clin Med 1977: 89: 712-723.